Appropriations For CDER, CBER Would Grow In FY 2012 Under House Bill That Keeps FDA Flat
This article was originally published in The Pink Sheet Daily
Executive Summary
Funding bill prepared for mark-up on May 24 relies on growth in user fees and reductions elsewhere in the FDA budget.